APO Research
Talk to an analyst

APO RESEARCH · REPORT

RNA Stabilizers

Compare research editions
View pricing & licenses

Selected research

Industry Research

RNA Stabilizers Industry Research Report 2026

26 December 2025138 pages

Choose your research edition.

Industry ResearchRNA Stabilizers Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal RNA Stabilizers Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal RNA Stabilizers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal RNA Stabilizers Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal RNA Stabilizers Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global RNA Stabilizers market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for RNA Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for RNA Stabilizers is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for RNA Stabilizers is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of RNA Stabilizers include Yeasen, YaJi Biological, NCM Biotech, Thermo Fisher Scientific, Vazyme, Merck, Maokangbio, Beyotime and Zymo Research, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global RNA Stabilizers market in terms of revenue (US$ million) and, where applicable, sales volume (L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/L) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

RNA Stabilizers Market by Company

Yeasen

YaJi Biological

NCM Biotech

Thermo Fisher Scientific

Vazyme

Merck

Maokangbio

Beyotime

Zymo Research

Takara Bio

SRL

Omega Bio-Tek

NZYtech

New England Biolabs

Genetix Biotech Asia

G-Biosciences

Dutscher

BioEntist

RNA Stabilizers Segment by Type

Solid Phase Stabilizers

Spray or Coating-Based Stabilizers

Solution-Based Stabilizers

RNA Stabilizers Segment by Application

Molecular Biology

Genomics

RNA Stabilizers Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RNA Stabilizers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of RNA Stabilizers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RNA Stabilizers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of RNA Stabilizers manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of RNA Stabilizers by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of RNA Stabilizers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global RNA Stabilizers Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global RNA Stabilizers Sales (L) of Manufacturers (2021-2026) Table 7. Global RNA Stabilizers Sales Market Share by Manufacturers (2021-2026) Table 8. Global RNA Stabilizers Revenue of Manufacturers (2021-2026) Table 9. Global RNA Stabilizers Revenue Share by Manufacturers (2021-2026) Table 10. Global Market RNA Stabilizers Average Price (US$/ml) of Manufacturers (2021-2026) Table 11. Global RNA Stabilizers Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of RNA Stabilizers, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of RNA Stabilizers, Product Type & Application Table 14. Global RNA Stabilizers Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global RNA Stabilizers by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Yeasen Company Information Table 19. Yeasen Business Overview Table 20. Yeasen RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 21. Yeasen RNA Stabilizers Product Portfolio Table 22. Yeasen Recent Developments Table 23. YaJi Biological Company Information Table 24. YaJi Biological Business Overview Table 25. YaJi Biological RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 26. YaJi Biological RNA Stabilizers Product Portfolio Table 27. YaJi Biological Recent Developments Table 28. NCM Biotech Company Information Table 29. NCM Biotech Business Overview Table 30. NCM Biotech RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 31. NCM Biotech RNA Stabilizers Product Portfolio Table 32. NCM Biotech Recent Developments Table 33. Thermo Fisher Scientific Company Information Table 34. Thermo Fisher Scientific Business Overview Table 35. Thermo Fisher Scientific RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 36. Thermo Fisher Scientific RNA Stabilizers Product Portfolio Table 37. Thermo Fisher Scientific Recent Developments Table 38. Vazyme Company Information Table 39. Vazyme Business Overview Table 40. Vazyme RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 41. Vazyme RNA Stabilizers Product Portfolio Table 42. Vazyme Recent Developments Table 43. Merck Company Information Table 44. Merck Business Overview Table 45. Merck RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 46. Merck RNA Stabilizers Product Portfolio Table 47. Merck Recent Developments Table 48. Maokangbio Company Information Table 49. Maokangbio Business Overview Table 50. Maokangbio RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 51. Maokangbio RNA Stabilizers Product Portfolio Table 52. Maokangbio Recent Developments Table 53. Beyotime Company Information Table 54. Beyotime Business Overview Table 55. Beyotime RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 56. Beyotime RNA Stabilizers Product Portfolio Table 57. Beyotime Recent Developments Table 58. Zymo Research Company Information Table 59. Zymo Research Business Overview Table 60. Zymo Research RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 61. Zymo Research RNA Stabilizers Product Portfolio Table 62. Zymo Research Recent Developments Table 63. Takara Bio Company Information Table 64. Takara Bio Business Overview Table 65. Takara Bio RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 66. Takara Bio RNA Stabilizers Product Portfolio Table 67. Takara Bio Recent Developments Table 68. SRL Company Information Table 69. SRL Business Overview Table 70. SRL RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 71. SRL RNA Stabilizers Product Portfolio Table 72. SRL Recent Developments Table 73. Omega Bio-Tek Company Information Table 74. Omega Bio-Tek Business Overview Table 75. Omega Bio-Tek RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 76. Omega Bio-Tek RNA Stabilizers Product Portfolio Table 77. Omega Bio-Tek Recent Developments Table 78. NZYtech Company Information Table 79. NZYtech Business Overview Table 80. NZYtech RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 81. NZYtech RNA Stabilizers Product Portfolio Table 82. NZYtech Recent Developments Table 83. New England Biolabs Company Information Table 84. New England Biolabs Business Overview Table 85. New England Biolabs RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 86. New England Biolabs RNA Stabilizers Product Portfolio Table 87. New England Biolabs Recent Developments Table 88. Genetix Biotech Asia Company Information Table 89. Genetix Biotech Asia Business Overview Table 90. Genetix Biotech Asia RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 91. Genetix Biotech Asia RNA Stabilizers Product Portfolio Table 92. Genetix Biotech Asia Recent Developments Table 93. G-Biosciences Company Information Table 94. G-Biosciences Business Overview Table 95. G-Biosciences RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 96. G-Biosciences RNA Stabilizers Product Portfolio Table 97. G-Biosciences Recent Developments Table 98. Dutscher Company Information Table 99. Dutscher Business Overview Table 100. Dutscher RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 101. Dutscher RNA Stabilizers Product Portfolio Table 102. Dutscher Recent Developments Table 103. BioEntist Company Information Table 104. BioEntist Business Overview Table 105. BioEntist RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 106. BioEntist RNA Stabilizers Product Portfolio Table 107. BioEntist Recent Developments Table 108. Global RNA Stabilizers Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global RNA Stabilizers Sales by Region (2021-2026) & (L) Table 110. Global RNA Stabilizers Sales Market Share by Region (2021-2026) Table 111. Global RNA Stabilizers Sales by Region (2027-2032) & (L) Table 112. Global RNA Stabilizers Sales Market Share by Region (2027-2032) Table 113. Global RNA Stabilizers Revenue by Region (2021-2026) & (US$ Million) Table 114. Global RNA Stabilizers Revenue Market Share by Region (2021-2026) Table 115. Global RNA Stabilizers Revenue by Region (2027-2032) & (US$ Million) Table 116. Global RNA Stabilizers Revenue Market Share by Region (2027-2032) Table 117. North America RNA Stabilizers Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America RNA Stabilizers Sales by Country (2021-2026) & (L) Table 119. North America RNA Stabilizers Sales by Country (2027-2032) & (L) Table 120. North America RNA Stabilizers Revenue by Country (2021-2026) & (US$ Million) Table 121. North America RNA Stabilizers Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe RNA Stabilizers Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe RNA Stabilizers Sales by Country (2021-2026) & (L) Table 124. Europe RNA Stabilizers Sales by Country (2027-2032) & (L) Table 125. Europe RNA Stabilizers Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe RNA Stabilizers Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific RNA Stabilizers Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific RNA Stabilizers Sales by Country (2021-2026) & (L) Table 129. Asia Pacific RNA Stabilizers Sales by Country (2027-2032) & (L) Table 130. Asia Pacific RNA Stabilizers Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific RNA Stabilizers Revenue by Country (2027-2032) & (US$ Million) Table 132. South America RNA Stabilizers Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America RNA Stabilizers Sales by Country (2021-2026) & (L) Table 134. South America RNA Stabilizers Sales by Country (2027-2032) & (L) Table 135. South America RNA Stabilizers Revenue by Country (2021-2026) & (US$ Million) Table 136. South America RNA Stabilizers Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa RNA Stabilizers Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa RNA Stabilizers Sales by Country (2021-2026) & (L) Table 139. Middle East and Africa RNA Stabilizers Sales by Country (2027-2032) & (L) Table 140. Middle East and Africa RNA Stabilizers Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa RNA Stabilizers Revenue by Country (2027-2032) & (US$ Million) Table 142. Global RNA Stabilizers Sales by Type (2021-2026) & (L) Table 143. Global RNA Stabilizers Sales by Type (2027-2032) & (L) Table 144. Global RNA Stabilizers Sales Market Share by Type (2021-2026) Table 145. Global RNA Stabilizers Sales Market Share by Type (2027-2032) Table 146. Global RNA Stabilizers Revenue by Type (2021-2026) & (US$ Million) Table 147. Global RNA Stabilizers Revenue by Type (2027-2032) & (US$ Million) Table 148. Global RNA Stabilizers Revenue Market Share by Type (2021-2026) Table 149. Global RNA Stabilizers Revenue Market Share by Type (2027-2032) Table 150. Global RNA Stabilizers Price by Type (2021-2026) & (US$/ml) Table 151. Global RNA Stabilizers Price by Type (2027-2032) & (US$/ml) Table 152. Global RNA Stabilizers Sales by Application (2021-2026) & (L) Table 153. Global RNA Stabilizers Sales by Application (2027-2032) & (L) Table 154. Global RNA Stabilizers Sales Market Share by Application (2021-2026) Table 155. Global RNA Stabilizers Sales Market Share by Application (2027-2032) Table 156. Global RNA Stabilizers Revenue by Application (2021-2026) & (US$ Million) Table 157. Global RNA Stabilizers Revenue by Application (2027-2032) & (US$ Million) Table 158. Global RNA Stabilizers Revenue Market Share by Application (2021-2026) Table 159. Global RNA Stabilizers Revenue Market Share by Application (2027-2032) Table 160. Global RNA Stabilizers Price by Application (2021-2026) & (US$/ml) Table 161. Global RNA Stabilizers Price by Application (2027-2032) & (US$/ml) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. RNA Stabilizers Distributors List Table 165. RNA Stabilizers Customers List Table 166. RNA Stabilizers Industry Trends Table 167. RNA Stabilizers Industry Drivers Table 168. RNA Stabilizers Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. RNA Stabilizers Product Image Figure 5. Global RNA Stabilizers Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global RNA Stabilizers Market Size (2021-2032) & (US$ Million) Figure 7. Global RNA Stabilizers Sales (2021-2032) & (L) Figure 8. Global RNA Stabilizers Average Price (US$/ml) & (2021-2032) Figure 9. Solid Phase Stabilizers Product Image Figure 10. Spray or Coating-Based Stabilizers Product Image Figure 11. Solution-Based Stabilizers Product Image Figure 12. Molecular Biology Product Image Figure 13. Genomics Product Image Figure 14. Global RNA Stabilizers Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of RNA Stabilizers, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 RNA Stabilizers Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global RNA Stabilizers Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global RNA Stabilizers Sales by Region in 2025 Figure 20. Global RNA Stabilizers Revenue by Region in 2025 Figure 21. North America RNA Stabilizers Market Size by Country in 2025 Figure 22. North America RNA Stabilizers Sales Market Share by Country (2021-2032) Figure 23. North America RNA Stabilizers Revenue Market Share by Country (2021-2032) Figure 24. United States RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe RNA Stabilizers Market Size by Country in 2025 Figure 28. Europe RNA Stabilizers Sales Market Share by Country (2021-2032) Figure 29. Europe RNA Stabilizers Revenue Market Share by Country (2021-2032) Figure 30. Germany RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific RNA Stabilizers Market Size by Country in 2025 Figure 41. Asia Pacific RNA Stabilizers Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific RNA Stabilizers Revenue Market Share by Country (2021-2032) Figure 43. China RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America RNA Stabilizers Market Size by Country in 2025 Figure 52. South America RNA Stabilizers Sales Market Share by Country (2021-2032) Figure 53. South America RNA Stabilizers Revenue Market Share by Country (2021-2032) Figure 54. Brazil RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Colombia RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa RNA Stabilizers Market Size by Country in 2025 Figure 59. Middle East and Africa RNA Stabilizers Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa RNA Stabilizers Revenue Market Share by Country (2021-2032) Figure 61. Egypt RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries RNA Stabilizers Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global RNA Stabilizers Sales Market Share by Type (2021-2032) Figure 67. Global RNA Stabilizers Revenue Market Share by Type (2021-2032) Figure 68. Global RNA Stabilizers Price (US$/ml) by Type (2021-2032) Figure 69. Global RNA Stabilizers Sales Market Share by Application (2021-2032) Figure 70. Global RNA Stabilizers Revenue Market Share by Application (2021-2032) Figure 71. Global RNA Stabilizers Price (US$/ml) by Application (2021-2032) Figure 72. RNA Stabilizers Value Chain Figure 73. RNA Stabilizers Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. RNA Stabilizers Industry Opportunities and Challenges

Scope & coverage.

Types
  • Solid Phase Stabilizers
  • Spray or Coating-Based Stabilizers
  • Solution-Based Stabilizers
Applications
  • Molecular Biology
  • Genomics
Companies covered
  • Yeasen
  • YaJi Biological
  • NCM Biotech
  • Thermo Fisher Scientific
  • Vazyme
  • Merck
  • Maokangbio
  • Beyotime
  • Zymo Research
  • Takara Bio
  • SRL
  • Omega Bio-Tek
  • NZYtech
  • New England Biolabs
  • Genetix Biotech Asia
  • G-Biosciences
  • Dutscher
  • BioEntist

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global RNA Stabilizers Market Size (2021-2032)
  4. 2.2.2 Global RNA Stabilizers Sales (2021-2032)
  5. 2.2.3 Global RNA Stabilizers Market Average Price (2021-2032)
  6. 2.3 RNA Stabilizers by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Solid Phase Stabilizers
  9. 2.3.3 Spray or Coating-Based Stabilizers
  10. 2.3.4 Solution-Based Stabilizers
  11. 2.4 RNA Stabilizers by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Molecular Biology
  14. 2.4.3 Genomics
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global RNA Stabilizers Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global RNA Stabilizers Sales (L) of Manufacturers (2021-2026)
  3. 3.3 Global RNA Stabilizers Revenue of Manufacturers (2021-2026)
  4. 3.4 Global RNA Stabilizers Average Price by Manufacturers (2021-2026)
  5. 3.5 Global RNA Stabilizers Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of RNA Stabilizers, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of RNA Stabilizers, Product Type & Application
  8. 3.8 Global Manufacturers of RNA Stabilizers, Established Date
  9. 3.9 Global RNA Stabilizers Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Yeasen
  2. 4.1.1 Yeasen Company Information
  3. 4.1.2 Yeasen Business Overview
  4. 4.1.3 Yeasen RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Yeasen RNA Stabilizers Product Portfolio
  6. 4.1.5 Yeasen Recent Developments
  7. 4.2 YaJi Biological
  8. 4.2.1 YaJi Biological Company Information
  9. 4.2.2 YaJi Biological Business Overview
  10. 4.2.3 YaJi Biological RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 YaJi Biological RNA Stabilizers Product Portfolio
  12. 4.2.5 YaJi Biological Recent Developments
  13. 4.3 NCM Biotech
  14. 4.3.1 NCM Biotech Company Information
  15. 4.3.2 NCM Biotech Business Overview
  16. 4.3.3 NCM Biotech RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 NCM Biotech RNA Stabilizers Product Portfolio
  18. 4.3.5 NCM Biotech Recent Developments
  19. 4.4 Thermo Fisher Scientific
  20. 4.4.1 Thermo Fisher Scientific Company Information
  21. 4.4.2 Thermo Fisher Scientific Business Overview
  22. 4.4.3 Thermo Fisher Scientific RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Thermo Fisher Scientific RNA Stabilizers Product Portfolio
  24. 4.4.5 Thermo Fisher Scientific Recent Developments
  25. 4.5 Vazyme
  26. 4.5.1 Vazyme Company Information
  27. 4.5.2 Vazyme Business Overview
  28. 4.5.3 Vazyme RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Vazyme RNA Stabilizers Product Portfolio
  30. 4.5.5 Vazyme Recent Developments
  31. 4.6 Merck
  32. 4.6.1 Merck Company Information
  33. 4.6.2 Merck Business Overview
  34. 4.6.3 Merck RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Merck RNA Stabilizers Product Portfolio
  36. 4.6.5 Merck Recent Developments
  37. 4.7 Maokangbio
  38. 4.7.1 Maokangbio Company Information
  39. 4.7.2 Maokangbio Business Overview
  40. 4.7.3 Maokangbio RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Maokangbio RNA Stabilizers Product Portfolio
  42. 4.7.5 Maokangbio Recent Developments
  43. 4.8 Beyotime
  44. 4.8.1 Beyotime Company Information
  45. 4.8.2 Beyotime Business Overview
  46. 4.8.3 Beyotime RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Beyotime RNA Stabilizers Product Portfolio
  48. 4.8.5 Beyotime Recent Developments
  49. 4.9 Zymo Research
  50. 4.9.1 Zymo Research Company Information
  51. 4.9.2 Zymo Research Business Overview
  52. 4.9.3 Zymo Research RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Zymo Research RNA Stabilizers Product Portfolio
  54. 4.9.5 Zymo Research Recent Developments
  55. 4.10 Takara Bio
  56. 4.10.1 Takara Bio Company Information
  57. 4.10.2 Takara Bio Business Overview
  58. 4.10.3 Takara Bio RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Takara Bio RNA Stabilizers Product Portfolio
  60. 4.10.5 Takara Bio Recent Developments
  61. 4.11 SRL
  62. 4.11.1 SRL Company Information
  63. 4.11.2 SRL Business Overview
  64. 4.11.3 SRL RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 SRL RNA Stabilizers Product Portfolio
  66. 4.11.5 SRL Recent Developments
  67. 4.12 Omega Bio-Tek
  68. 4.12.1 Omega Bio-Tek Company Information
  69. 4.12.2 Omega Bio-Tek Business Overview
  70. 4.12.3 Omega Bio-Tek RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Omega Bio-Tek RNA Stabilizers Product Portfolio
  72. 4.12.5 Omega Bio-Tek Recent Developments
  73. 4.13 NZYtech
  74. 4.13.1 NZYtech Company Information
  75. 4.13.2 NZYtech Business Overview
  76. 4.13.3 NZYtech RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 NZYtech RNA Stabilizers Product Portfolio
  78. 4.13.5 NZYtech Recent Developments
  79. 4.14 New England Biolabs
  80. 4.14.1 New England Biolabs Company Information
  81. 4.14.2 New England Biolabs Business Overview
  82. 4.14.3 New England Biolabs RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 New England Biolabs RNA Stabilizers Product Portfolio
  84. 4.14.5 New England Biolabs Recent Developments
  85. 4.15 Genetix Biotech Asia
  86. 4.15.1 Genetix Biotech Asia Company Information
  87. 4.15.2 Genetix Biotech Asia Business Overview
  88. 4.15.3 Genetix Biotech Asia RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Genetix Biotech Asia RNA Stabilizers Product Portfolio
  90. 4.15.5 Genetix Biotech Asia Recent Developments
  91. 4.16 G-Biosciences
  92. 4.16.1 G-Biosciences Company Information
  93. 4.16.2 G-Biosciences Business Overview
  94. 4.16.3 G-Biosciences RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 G-Biosciences RNA Stabilizers Product Portfolio
  96. 4.16.5 G-Biosciences Recent Developments
  97. 4.17 Dutscher
  98. 4.17.1 Dutscher Company Information
  99. 4.17.2 Dutscher Business Overview
  100. 4.17.3 Dutscher RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Dutscher RNA Stabilizers Product Portfolio
  102. 4.17.5 Dutscher Recent Developments
  103. 4.18 BioEntist
  104. 4.18.1 BioEntist Company Information
  105. 4.18.2 BioEntist Business Overview
  106. 4.18.3 BioEntist RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 BioEntist RNA Stabilizers Product Portfolio
  108. 4.18.5 BioEntist Recent Developments
5 Global RNA Stabilizers Market Scenario by Region
  1. 5.1 Global RNA Stabilizers Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global RNA Stabilizers Sales by Region: 2021-2032
  3. 5.2.1 Global RNA Stabilizers Sales by Region: 2021-2026
  4. 5.2.2 Global RNA Stabilizers Sales by Region: 2027-2032
  5. 5.3 Global RNA Stabilizers Revenue by Region: 2021-2032
  6. 5.3.1 Global RNA Stabilizers Revenue by Region: 2021-2026
  7. 5.3.2 Global RNA Stabilizers Revenue by Region: 2027-2032
  8. 5.4 North America RNA Stabilizers Market Facts & Figures by Country
  9. 5.4.1 North America RNA Stabilizers Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America RNA Stabilizers Sales by Country (2021-2032)
  11. 5.4.3 North America RNA Stabilizers Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe RNA Stabilizers Market Facts & Figures by Country
  16. 5.5.1 Europe RNA Stabilizers Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe RNA Stabilizers Sales by Country (2021-2032)
  18. 5.5.3 Europe RNA Stabilizers Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific RNA Stabilizers Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific RNA Stabilizers Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific RNA Stabilizers Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific RNA Stabilizers Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America RNA Stabilizers Market Facts & Figures by Country
  41. 5.7.1 South America RNA Stabilizers Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America RNA Stabilizers Sales by Country (2021-2032)
  43. 5.7.3 South America RNA Stabilizers Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa RNA Stabilizers Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa RNA Stabilizers Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa RNA Stabilizers Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa RNA Stabilizers Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global RNA Stabilizers Sales by Type (2021-2032)
  2. 6.1.1 Global RNA Stabilizers Sales by Type (2021-2032) & (L)
  3. 6.1.2 Global RNA Stabilizers Sales Market Share by Type (2021-2032)
  4. 6.2 Global RNA Stabilizers Revenue by Type (2021-2032)
  5. 6.2.1 Global RNA Stabilizers Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global RNA Stabilizers Revenue Market Share by Type (2021-2032)
  7. 6.3 Global RNA Stabilizers Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global RNA Stabilizers Sales by Application (2021-2032)
  2. 7.1.1 Global RNA Stabilizers Sales by Application (2021-2032) & (L)
  3. 7.1.2 Global RNA Stabilizers Sales Market Share by Application (2021-2032)
  4. 7.2 Global RNA Stabilizers Revenue by Application (2021-2032)
  5. 7.2.1 Global RNA Stabilizers Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global RNA Stabilizers Revenue Market Share by Application (2021-2032)
  7. 7.3 Global RNA Stabilizers Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 RNA Stabilizers Value Chain Analysis
  2. 8.1.1 RNA Stabilizers Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 RNA Stabilizers Production Mode & Process
  5. 8.2 RNA Stabilizers Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 RNA Stabilizers Distributors
  8. 8.2.3 RNA Stabilizers Customers
9 Global RNA Stabilizers Analyzing Market Dynamics
  1. 9.1 RNA Stabilizers Industry Trends
  2. 9.2 RNA Stabilizers Industry Drivers
  3. 9.3 RNA Stabilizers Industry Opportunities and Challenges
  4. 9.4 RNA Stabilizers Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst